Abiopharma

🔍 Holme Timothy (Executive)

Company: QuantumScape Corp (QS)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 548,960 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: false | shares_owned_after: 1,657,142.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 109,792 shares of Class A Common Stock (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: false | shares_owned_after: 1,766,934.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The Issuer granted restricted stock units ("RSUs") (40%) and performance restricted stock units ("PSUs") (60%) to the Reporting Person. Each RSU and PSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer. The RSUs vest each quarter and the PSUs vest upon achievement of certain performance milestones, in both cases subject to the Reporting Person's continued service as of each vesting date.
• F2: The Issuer granted RSUs to the Reporting Person. Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer. The RSUs are eligible to vest based on the Issuer's total shareholder return ("TSR") relative to certain indexed companies during a performance period beginning on January 1, 2026 and ending on December 31, 2028, subject to the Reporting Person's continued service as of each vesting date.
• F3: Includes 1,637,100 shares represented by RSUs and PSUs. Each RSU/PSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer. The RSUs vest each quarter and the PSUs vest upon achievement of certain performance milestones, in both cases subject to the Reporting Person's continued service as of each vesting date.